This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Hsi: It's been a ...
In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...
We present the case of a patient with an elevated prostate-specific antigen level who underwent a prostate MRI that revealed a mass between the prostate and rectum, prompting further evaluation.
A 73-year-old male with a history of relapsed/refractory NK T-cell lymphoma, s/p chemo and immune checkpoint inhibitors therapy. The patient now presents with new onset nephrotic syndrome and acute ...
Racial and Ethnic Differences in Advance Care Planning Among Patients With Cancer: Impact of Terminal Illness Acknowledgment, Religiousness, and Treatment Preferences A cohort of 1,314 cases of PTCL ...
Spotlight Pathology, a Sci-Tech Daresbury-based University of Manchester spin‑out developing AI‑powered tools for blood cancer diagnostics, has secured a new investment of £1.4 million to accelerate ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Non-Hodgkin’s lymphoma (NHL) is a group of over 60 subtypes of cancer that originate in the lymphocytes, which are white blood cells within the lymphatic system. NHL subtypes are categorized based on ...
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...
Doctors categorize non-Hodgkin lymphoma as aggressive if it grows and spreads quickly. There are many types, and they typically require immediate treatment. Lymphomas can begin anywhere in the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results